NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Mar 20 2026

· Issued by NATCO Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-20-2026-5

Natco Pharma Limited has informed the Exchange regarding a press release dated March 20, 2026, titled "NATCO Pharma Launches Semaglutide Generic Injection Multi Dose Vials in India at the Most Affordable Price Starting from MRP INR 1,290".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases